The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

The Role of Lenvatinib in NSCLC Treatment

Lars Bastholt, MD
Published Online: 3:32 PM, Wed October 19, 2016

Lars Bastholt, MD, clinical oncologist, Odense University Hospital, discusses the role of lenvatinib in treating patients with non-small cell lung cancer (NSCLC).

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.